Colonic drug delivery: Prodrug approach

Pharmaceutical Research

Volumn 18, Issue 5, 2001, Pages 557-564

  Sinha, V R ^a   Kumria, R ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Colon drug delivery; Colon specific drug delivery; Conjugates; Prodrugs

Indexed keywords

ANTIINFLAMMATORY AGENT; AZO COMPOUND; AZO REDUCTASE; BUDESONIDE; CYCLODEXTRIN DERIVATIVE; DEXAMETHASONE; DEXTRAN DERIVATIVE; ESTERASE; GLUCURONIDE; GLYCOSIDE; IPSALAZIDE; NITROREDUCTASE; OLSALAZINE; PEPPERMINT OIL; PEPTIDE; POLYMER; PRODRUG; PROTEIN; SALAZOSULFAPYRIDINE; URSODEOXYCHOLIC ACID;

COLON; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG TRANSFORMATION; HUMAN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STRUCTURE ANALYSIS;

ANIMALS; COLON; DRUG DELIVERY SYSTEMS; HUMANS; PRODRUGS;

EID: 0034956847     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011033121528     Document Type: Review

References (58)

1. Intestinal microflora
2. The human intestinal microflora
3. Discussion of current bacteriologic investigations of the relationships between intestinal flora, diet and colon cancer
4. Microbially controlled drug delivery to the colon
5. Metabolism of foreign compounds by gastrointestinal microorganisms
6. The colon as a site for drug delivery
7. A colon-specific drug delivery system based on drug glycosides and the glycosidases of colonic bacteria
8. A-[[(4-biphenylyl)acetyl] amino]-α-,-β- and -γ-cyclodextrins: Potential prodrugs for colon specific delivery
9. Colon specific drug delivery based on cyclodextrin prodrug: Release behaviour of biphenylyl acetic acid from its cyclodextrin conjugates in rat intestinal tract after oral administration
10. A novel pro-drug of salicylic acid, salicylic acid-glutamic acid conjugate utilizing hydrolysis in rabbit intestinal microorganisms
11. Hydrolysis of salicylic acid-tyrosine salicylic acid-methionine prodrugs in rabbits
12. Effect of oral pretreatment with antibiotics on the hydrolysis of salicylic acid-tyrosine and salicylic acid methionine prodrugs in rabbit intestinal microorganisms
13. Unequal hydrolysis of salicylic acid-D-alanine and salicylic acid-L-alanine conjugate in rabbit intestinal microorganisms
14. Synthesis and evaluation of 5-aminosalicyl-glycine as a potential colon specific prodrug of 5-aminosalicyclic acid
15. In vitro study for the assessment of poly(L-Aspartic acid) as a drug carrier for colon-specific drug delivery
16. In vivo pharmacokinetics study for the assessment of poly(L-Aspartic acid) as a drug carrier for colon specific drug delivery
17. Metabolism of sennosides by human intestinal bacteria
18. Transport of Biological Lipophills: Effect of lipophilic structure
19. Glycosidase in the mammalian alimentary canal
20. Approaches and opportunities in colon-specific drug delivery
21. Drug glycosides: Potential pro-drugs for colon-specific drug delivery
22. Drug glycosides in oral colon-specific drug delivery
23. Relative antiinflammatory effect of oral dexamethasone-β-D-glucoside and dexamethasone in experimental inflammatory bowel disease in guinea pig
24. Drug metabolism by intestinal microorganism
25. Evidence for the delivery of narcotic antagonists to the colon as their glucuronide conjugates
26. In vitro evaluation of dexamethasone-β-D-glucuronide for colon-specific drug delivery
27. A budesonide prodrug accelerates treatment of colitis in rats
28. Steady-state pharmacokinetics of corticosteroid delivery from glucuronide prodrugs in normal and colitic rats
29. Menthol-β-D-glucuronide: A potential prodrug for treatment of the irritable bowel syndrome
30. The site specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation
31. N-(2-hydroxypropyl)methacrylamide copolymers for colon-specific drug delivery
32. Use of azo polymers for colon-specific drug delivery
33. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-Aminosalicylic acid
34. Optimum dose of olsalazine for maintaining remission in ulcerative colitis
35. A Polymeric drug for treatment of inflammatory bowel disease
36. Treatment of chronic ulcerative colitis with poly-ASA: A new non-absorbable carrier for release of 5-aminosalicylate in the colon
37. Release of 5-aminosali-cyclic acid (5-ASA) from BW73Y: In vitro and in vivo studies in humans
38. The potential of water-soluble polymeric carriers in targeted and site-specific drug delivery
39. Polymers for colon-specific drug delivery
40. The relation between swelling properties and enzymatic degradation of azo-polymers
41. Release of 5-amino salicylic acid from acrylic type polymeric prodrugs designed for colon specific drug delivery
42. Fate of β-cyclodextrins in the human intestine
43. 14C-β-cylodextrin in rat
44. In vitro evaluation of Biphenylyl acetic acid-β-cyclodextrin conjugates as colon-targeting prodrugs: Drug Release Behaviour in rat biological media
45. Investigations on dextranase 1. On the occurrence and the assay of dextranase
46. Degradation of dextrans by enzymes of intestinal bacteria
47. The splitting of dextran and isomaltose by animal tissues
48. Dextran-splitting anaerobic bacteria from the human intestine
49. Hydrolysis of ester type drugs by the purified esterases from human intestinal mucosa
50. Macromolecular pro-drugs. VI coupling of the highly lipophilic agent naproxen to dextran and in vitro characterization of the conjugates
51. Macromolecular pro-drug X. Bioavailability of naproxen after oral administration of dextran-naproxen ester conjugates in rabbits
52. Macro-molecular prodrug XIV. Absorption characteristics of naproxen after oral administration of dextran T-70-naproxen ester prodrug in pigs
53. Macro-molecular prodrug XV. Colon-targeted delivery-bioavailability of naproxen from orally administered dextran-naproxen ester pro-drugs varying in molecular size in the pig
54. Synthesis and chemical stability of glucocorticoid-dextran esters: Potential pro-drugs for colon-specific delivery
55. Glucocorticoid-dextran conjugate as potential prodrug for colon-specific delivery: Hydrolysis in rat gastrointestinal tract contents
56. Polymers of colon-specific drug delivery
57. Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem
58. Synthesis and properties of dextran-5-aminosalicyclic acid ester as a potential colon-specific prodrug of 5-aminosalicyclic acid